Abstract
BackgroundDietary fish is a rich source of Omega-3 poly-unsaturated fatty acids (PUFAs). These compounds may have protective effect against cardiovascular events possibly by modifying lipid profiles. Consequently, fish oil supplements are produced commercially to complement low fish intake. It is not clear if both interventions have similar effects. The aim of this trial was to compare the anti-hyperlipidemic effect of omega3 fatty acid supplements with fresh fish.MethodA total of 106 patients with hyperlipidemia were randomized. One group received 2 g/day of omega-3 capsules for a period of 8 weeks and the other group received a mean of 250 g trout fish twice weekly (for dinner and lunch) for the same time period. The effects of these diets on the lipid profile after the intervention were compared between the two groups.ResultsData from 48 patients in fish oil group and 47 patients from fish group was used for final analysis. In both groups, total cholesterol, non-HDL cholesterol, triglyceride (TG) levels, and Castelli I index (total cholesterol/HDL ratio) were reduced significantly following the treatment; however, dietary-fish intake had a more pronounced effect (−85.08 ± 74.82 vs. −30.75 ± 89.00, P < 0.001; 75.06 ± 35.43 vs. −16.93 ± 40.21, P < 0.001; −66.55 ± 30.79 vs. −12.7 ± 35.48, P = 0.003; and −0.77 ± 1.39 vs. −3.02 ± 1.85, P < 0.001; respectively). HDL level was increased in both groups with a higher effect in dietary fish group (4.47 ± 7.83 vs. 8.51 ± 8.79, P = 0.022). Atherogenic (Log [TG/HDL ratio]) and Castelli II (LDL/HDL ratio) indices did not change in fish oil group while were reduced significantly by fresh fish consumption (−0.04 ± 0.27 vs. −0.26 ± 0.17, P < 0.001; and 0.15 ± 0.7 vs. -1.32 ± 1.15, P < 0.001, respectively). LDL level was increased in the supplementation group, while it was significantly reduced in the dietary-fish group (+18.7 ± 24.97 vs. −22.75 ± 27.28, P < 0.001).ConclusionConsumption of fresh fish seems to be superior in positively modifying the lipid profiles which may have important translations in the occurrence of cardiovascular events.
Highlights
Cardiovascular disease (CVD) is the major cause of death worldwide with an increasing trend in developingA 1-mg/dl increase in the low-density lipoprotein (LDL)Nutrition and DiabetesZibaeenezhad et al Nutrition and Diabetes (2017)7:1 level associates with a 2–3% increase in risk for CVDs, and elevations earlier in life may be associated with higher increases in risk
Atherogenic (Log [TG/High-density lipoprotein (HDL) ratio]) and Castelli II (LDL/HDL ratio) indices did not change in fish oil group while were reduced significantly by fresh fish consumption (−0.04 ± 0.27 vs. −0.26 ± 0.17, P < 0.001; and 0.15 ± 0.7 vs. -1.32 ± 1.15, P < 0.001, respectively)
Consumption of fresh fish seems to be superior in positively modifying the lipid profiles which may have important translations in the occurrence of cardiovascular events
Summary
Cardiovascular disease (CVD) is the major cause of death worldwide with an increasing trend in developingA 1-mg/dl increase in the low-density lipoprotein (LDL)Nutrition and DiabetesZibaeenezhad et al Nutrition and Diabetes (2017)7:1 level associates with a 2–3% increase in risk for CVDs, and elevations earlier in life may be associated with higher increases in risk. High-density lipoprotein (HDL) cholesterol independently predicts CVDs as well. Every 1-mg/dl decrease in HDL-cholesterol causes a 3–4% increase in the risk[3, 4] Other indices such as cholesterol ratio or Castelli I index (ratio of total cholesterol to HDLcholesterol), Castelli II index (LDL/HDL), and atherogenic index (log of Triglyceride to HDL-cholesterol ratio) may predict CVD risk better than LDL alone[6]. Dietary fish is a rich source of Omega-3 poly-unsaturated fatty acids (PUFAs). These compounds may have protective effect against cardiovascular events possibly by modifying lipid profiles. Fish oil supplements are produced commercially to complement low fish intake It is not clear if both interventions have similar effects. The aim of this trial was to compare the anti-hyperlipidemic effect of omega[3] fatty acid supplements with fresh fish
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.